SUPERNUS PHARMACEUTICALS, INC. (SUPN) Operating cash flow 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$47.3MFY2025 · since FY2016: $66.8M → $47.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $47.3M | -72.5% |
| FY2024 | $172.0M | +54.8% |
| FY2023 | $111.1M | -4.9% |
| FY2022 | $116.8M | -8.1% |
| FY2021 | $127.1M | -8.1% |
| FY2020 | $138.4M | -3.3% |
| FY2019 | $143.1M | +11.0% |
| FY2018 | $129.0M | +12.5% |
| FY2017 | $114.6M | +71.6% |
| FY2016 | $66.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice